NEW YORK. - Friday, April 10th 2015 [ME NewsWire]

(BUSINESS WIRE) Regulatory News:

Pershing Square Capital Management, L.P. has confirmed that on April 9, 2015 the parties to the lawsuit entitled Allergan, Inc., et al. v. Valeant Pharmaceuticals International, Inc., et al., No. 14-1214 DOC (ANx) (C.D. Cal.) have executed and filed with the court a Joint Stipulation of Voluntary Dismissal, dismissing the action.

About Pershing Square Capital Management, L.P.

Pershing Square Capital Management, L.P., based in New York City, is a SEC-registered investment advisor to private investment funds and to Pershing Square Holdings, Ltd.

About Pershing Square Holdings, Ltd.

Pershing Square Holdings, Ltd. is a concentrated, research-intensive, fundamental value investor in the public markets.

Contacts

Rubenstein Associates

Fran McGill, 212-843-9353

Fmcgill@rubenstein.com

StockWell Communications

Tim Burt, +44 (0)20 7240 2486

Tim.Burt@stockwellgroup.com

Permalink: http://www.me-newswire.net/news/14255/en